SCHOTT Pharma has announced an investment of €100m ($114m) to expand its manufacturing capacity for sterile RTU cartridges.

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are medicines that help the body lower blood sugar levels. They work ...

Women using weight-loss injections like Ozempic and Mounjaro are being warned to use contraception, as surprise pregnancies ...

Simple Promise's Revolutionary GLP-1 Electrolyte Formula Blends Hydration with Metabolic Support for Real, Sustainable Weight ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

Drug major Cipla has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard ...

Reviewing the bioequivalence study of the antidiabetic drug Semaglutide of MSN Laboratories, the Subject Expert Committee ...

Mounjaro is the brand name for tirzepatide, a prescription medication developed by Eli Lilly that is primarily used to treat ...

It is important to note that Ozempic and blindness are not usually connected, and vision loss is not a commonly reported or an expected side effect of this weight loss drug. However, if you are on ...

Ozempic teeth is the latest concern associated with the ‘miracle’ weight loss drug Ozempic Read to know more about this side ...